Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Guido Jordine is active.

Publication


Featured researches published by Guido Jordine.


Regulatory Toxicology and Pharmacology | 2017

A consortium-driven framework to guide the implementation of ICH M7 Option 4 control strategies

Chris Barber; Vincent Antonucci; Jens-Christoph Baumann; Roland Brown; Elizabeth Covey-Crump; David Elder; Eric Elliott; Jared W. Fennell; Fabrice Gallou; Nathan Ide; Guido Jordine; Jeffrey M. Kallemeyn; Dirk Lauwers; Adam R. Looker; Lucie E. Lovelle; Mark McLaughlin; Robert Molzahn; Martin Ott; Didier Schils; Rolf Schulte Oestrich; Neil Stevenson; Pere Talavera; Andrew Teasdale; Michael W.J. Urquhart; David L. Varie; Dennie S. Welch

ABSTRACT The ICH M7 Option 4 control of (potentially) mutagenic impurities is based on the use of scientific principles in lieu of routine analytical testing. This approach can reduce the burden of analytical testing without compromising patient safety, provided a scientifically rigorous approach is taken which is backed up by sufficient theoretical and/or analytical data. This paper introduces a consortium‐led initiative and offers a proposal on the supporting evidence that could be presented in regulatory submissions. Graphical abstract Figure. No caption available. HighlightsICH M7 Option 4 permits the use of predicted purges in lieu of analytical testing of mutagenic impurities.Predicted purge factors derived from expert knowledge or experimental data can be derived for stages in a synthesis.Thresholds of the predicted purge over the required purges can ensure a negligible risk from a mutagenic impurity.The level of scientific support needed to defend a purge estimate has been proposed.


Archive | 1999

Production of 2-amino-2-[2- (4-alkylphenyl) ethyl] propane-1, 3-diols

Stephan Abel; Tetsuro Fujita; Ryoji Akashi Hirose; Guido Jordine; Tadashi Hirakata-shi Mishina


Archive | 2009

CRYSTALLINE FORMS OF FINGOLIMOD HCL

Michael Mutz; Guido Jordine


Archive | 2003

Polymorphis of a known thiophenecarboxylic acid dodecahydrocyclopenta (a) phenanthrenyl ester

Guido Jordine; Michael Mutz


Archive | 1997

Process for trichromatic dyeing or printing

Guido Jordine; Jean-Marie Adam


Archive | 2009

Salts of fingolimod

Michael Mutz; Guido Jordine


Archive | 1996

Fiber-reactive monoazo dyes containing a phenylamino-substituted triazinyl group

Guido Jordine; Jean-Marie Adam


Archive | 2010

Ceramide-analogous metabolites

Volker Brinkmann; Guido Jordine; Markus Zollinger; Claudia Sayer


Archive | 2003

Production of 2-amin-2-&lsqb 2-(2-(40-C2-20-alkyl-phenyl)ethyl&rsqb propane-1,3-diols

Stephan Abel; Tetsuro Fujita; Ryoji Kobe-shi Hirose; Guido Jordine; Tadashi Yoshitomi Phar Mishina


Archive | 1993

Fiber-reactive monoazo dyes having A2-vinylsulfonyl-5-haloacryloylaniline diazo component or the like

Jean-Marie Adam; Guido Jordine

Collaboration


Dive into the Guido Jordine's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge